These findings indicated that a positive correlation between ALDH2 rs671 polymorphism and Aβ pathology should be considered when applying antibodies for Aβ plaques or oligomers clearance or when the ratio of Aβ peptide segments as a diagnostic marker for AD in East Asia. This evidence concerns the gene ALDH2 and Alzheimer disease.